Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ventilator Associated Bacterial Pneumonia (VABP)”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableStudy completedNCT04107363
What this trial is testing

Oropharyngeal Aspiration to Reduce Ventilator-Related Pneumonia

Who this might be right for
Ventilator-associated Bacterial Pneumonia
Ayşe AKBIYIK 40
Not applicableStudy completedNCT02420366
What this trial is testing

Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

Who this might be right for
Urinary Tract Infection, ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+2 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 257
Not applicableStudy completedNCT02728518
What this trial is testing

Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

Who this might be right for
Pneumonia
National Heart Institute, Egypt 133
Large-scale testing (Phase 3)WithdrawnNCT06168734
What this trial is testing

Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP

Who this might be right for
Ventilator-associated PneumoniaHospital-acquired Pneumonia
Venatorx Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT02168946
What this trial is testing

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Who this might be right for
Urinary Tract Infection ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+3 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 77
Testing effectiveness (Phase 2)Study completedNCT06086626
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Who this might be right for
Gram-Negative Bacterial Infections
Shionogi 30
Large-scale testing (Phase 3)Study completedNCT03894046
What this trial is testing

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

Who this might be right for
Acinetobacter Baumannii-calcoaceticus ComplexHospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia+2 more
Entasis Therapeutics 207
Large-scale testing (Phase 3)Looking for participantsNCT07089186
What this trial is testing

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Who this might be right for
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd. 80
Large-scale testing (Phase 3)WithdrawnNCT03006679
What this trial is testing

Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

Who this might be right for
Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial PneumoniaHospital-Acquired Pneumonia+1 more
Melinta Therapeutics, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07431307
What this trial is testing

Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Who this might be right for
Ventilator Associated Bacterial Pneumonia (VABP)Hospital Acquired Bacterial Pneumonia (HABP)Blood Stream Infection+2 more
BioVersys AG
Large-scale testing (Phase 3)Ended earlyNCT03409679
What this trial is testing

Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa

Who this might be right for
Pneumonia
Polyphor Ltd. 41
Early research (Phase 1)Looking for participantsNCT06801223
What this trial is testing

Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Innoviva Specialty Therapeutics 48
Post-approval studies (Phase 4)Looking for participantsNCT07004049
What this trial is testing

Optimising TREATment for Severe Gram-Negative Bacterial Infections

Who this might be right for
Bloodstream InfectionVentilator Associated Bacterial PneumoniaHospital Acquired Bacterial Pneumonia+2 more
National University of Singapore 600
Large-scale testing (Phase 3)Study completedNCT05905055
What this trial is testing

P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales

Who this might be right for
Complicated Urinary Tract InfectionAcute PyelonephritisHospital-acquired Bacterial Pneumonia+2 more
Meiji Seika Pharma Co., Ltd. 126
Not applicableStudy completedNCT02288234
What this trial is testing

Telavancin Observational Use Registry (TOUR)

Who this might be right for
Hospital Acquired Bacterial PneumoniaComplicated Skin and Skin Structure InfectionsVentilator Associated Bacterial Pneumonia+1 more
Cumberland Pharmaceuticals 1,063
Large-scale testing (Phase 3)Study completedNCT03583333
What this trial is testing

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

Who this might be right for
Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial Pneumonia
Merck Sharp & Dohme LLC 274
Testing effectiveness (Phase 2)Study completedNCT04215991
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants

Who this might be right for
Gram-negative Bacterial InfectionsHospital Acquired Bacterial Pneumonia (HABP)Complicated Urinary Tract Infection (cUTI)+1 more
Shionogi 91
Large-scale testing (Phase 3)Study completedNCT03032380
What this trial is testing

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

Who this might be right for
Healthcare-associated Pneumonia (HCAP)Hospital Acquired Pneumonia (HAP)Ventilator Associated Pneumonia (VAP)
Shionogi 300
Testing effectiveness (Phase 2)Looking for participantsNCT06841731
What this trial is testing

A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

Who this might be right for
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)
Jiangsu HengRui Medicine Co., Ltd. 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07512596
What this trial is testing

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Who this might be right for
Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 48
Load More Results
120